U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT06862700) titled 'Effect of Reduced Vasopressors on Mortality in ECMO-supported Cardiogenic Shock Patients' on Feb. 26.
Brief Summary: The goal of this observational study is to learn about the association between vasopressor exposure levels and outcomes in adults with cardiogenic shock receiving VA-ECMO. The main question it aims to answer is:
Does reduced exposure to vasopressors lower the 30-day mortality in patients with cardiogenic shock when receiving ECMO support? Participants who are receiving ECMO support for cardiogenic shock as part of their regular medical care will have their data collected, including information about their vasopressor...